Diligence memo · auto-generated · as of July 2, 2026
Diabetes America, Inc.
Diabetes America, Inc. looks fair against its niche peers and is dormant on financing cadence.
Businessfiled
Diabetes America, Inc. operates in Other Health Care, based in HOUSTON.
No verified homepage on file yet — operating evidence is limited to the public record.
Capital & rounds (filed)filed
Diabetes America, Inc. has raised $8.3M in disclosed capital across 1 recorded round, aggregated from public filings. Its latest round is modeled as Series A (a $4.0M–$15M round).
Largest single filing: $8.3M on 2007-09-13.
Most recent recorded round closed around 2007-09-13.
Valuation (modeled)modeled
Provath models Diabetes America, Inc. at approximately $167M (range $11M–$907M). This is an algorithmic estimate from round sizes and same-niche peers — not a quoted or reported figure.
Read: Fair. Modeled value is 1.33× the median modeled value of Series A Other Health Care companies in 2007–2009 (48 peers) — value vs value, same stage and era. Within the normal band (133% of peer median) for its niche.
Financing rhythm & timingmixed
Last raise 18.8 yr ago; this sector typically re-raises about every 14 months.
Only one round on record and long silent — often defunct, acquired, or gone quiet.
Comparablesmixed
Capital scale ranks ahead of 73% of Other Health Care peers (5377 compared).
Modeled value ranks above 86% of those peers.
Closest niche peers: Dynova Laboratories Inc, Vocollect Inc, Salient Surgical Technologies, Inc., Orthohelix Surgical Design Inc, CardioPolymers, Inc..
Peoplefiled
5 named people on file across officers, directors and signatories.
Risks & flagsmixed
Financing has been silent well beyond sector cadence — possibly defunct, acquired, or paused.
No clearly named CEO/founder/principal in the surfaced records — key-person evidence is thin.